image
Tilray Brands, Inc. TLRY
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
Watchlist
$ 1.2
1.69 %
$ 1.13 B
Market Cap
-4.0
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one TLRY stock under the worst case scenario is HIDDEN Compared to the current market price of 1.2 USD, Tilray Brands, Inc. is HIDDEN

TLRY Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one TLRY stock under the base case scenario is HIDDEN Compared to the current market price of 1.2 USD, Tilray Brands, Inc. is HIDDEN

TLRY Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Jan, 18, 2025.

The intrinsic value of one TLRY stock under the best case scenario is HIDDEN Compared to the current market price of 1.2 USD, Tilray Brands, Inc. is HIDDEN

TLRY Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart TLRY

image
1M 3%
6M -58.0%
1Y -67%
3Y -393%
5Y -1657%
All
FINANCIALS
789 M REVENUE
25.80%
Growth Rates
1Year 25.80%
3Years 15.42%
5Years 35.11%
7Years 75.85%
10Years 0.00%
-175 M OPERATING INCOME
87.24%
Growth Rates
1Year 87.24%
3Years -228.11%
5Years -132.01%
7Years -108.12%
10Years -128.35%
-222 M NET INCOME
84.59%
Growth Rates
1Year 84.59%
3Years 12.85%
5Years -78.73%
7Years -84.35%
10Years -135.72%
-30.9 M OPERATING CASH FLOW
-390.91%
Growth Rates
1Year -390.91%
3Years 11.59%
5Years 5.54%
7Years -36.47%
10Years -93.89%
128 M INVESTING CASH FLOW
145.02%
Growth Rates
1Year 145.02%
3Years 40.67%
5Years 24.38%
7Years 16.17%
10Years 131.96%
-75.2 M FINANCING CASH FLOW
-107.17%
Growth Rates
1Year -107.17%
3Years -17.08%
5Years -2.66%
7Years -4.81%
10Years 0.00%
200 M REVENUE
-12.98%
Growth Rates
1Year 25.80%
3Years 15.42%
5Years 35.11%
7Years 75.85%
10Years 0.00%
-36.6 M OPERATING INCOME
-77.54%
Growth Rates
1Year 87.24%
3Years -228.11%
5Years -132.01%
7Years -108.12%
10Years -128.35%
-34.7 M NET INCOME
-9.15%
Growth Rates
1Year 84.59%
3Years 12.85%
5Years -78.73%
7Years -84.35%
10Years -135.72%
-35.3 M OPERATING CASH FLOW
-113.44%
Growth Rates
1Year -390.91%
3Years 11.59%
5Years 5.54%
7Years -36.47%
10Years -93.89%
-49.4 M INVESTING CASH FLOW
-112.85%
Growth Rates
1Year 145.02%
3Years 40.67%
5Years 24.38%
7Years 16.17%
10Years 131.96%
60.6 M FINANCING CASH FLOW
666.04%
Growth Rates
1Year -107.17%
3Years -17.08%
5Years -2.66%
7Years -4.81%
10Years 0.00%
Balance Sheet Tilray Brands, Inc.
image
Current Assets 678 M
Cash & Short-Term Investments 261 M
Receivables 102 M
Other Current Assets 315 M
Non-Current Assets 3.66 B
Long-Term Investments 7.86 M
PP&E 574 M
Other Non-Current Assets 3.08 B
Current Liabilities 299 M
Accounts Payable 105 M
Short-Term Debt 39 M
Other Current Liabilities 155 M
Non-Current Liabilities 593 M
Long-Term Debt 348 M
Other Non-Current Liabilities 245 M
EFFICIENCY
Earnings Waterfall Tilray Brands, Inc.
image
Revenue 789 M
Cost Of Revenue 566 M
Gross Profit 223 M
Operating Expenses 398 M
Operating Income -175 M
Other Expenses 47.7 M
Net Income -222 M
RATIOS
28.31% GROSS MARGIN
28.31%
Averages
1Year 28.31%
3Years 23.44%
5Years 25.91%
7Years 35.36%
10Years 37.51%
-22.15% OPERATING MARGIN
-22.15%
Averages
1Year -22.15%
3Years -72.05%
5Years -40.79%
7Years -34.16%
10Years -87.46%
-31.05% NET MARGIN
-31.05%
Averages
1Year -31.05%
3Years -110.08%
5Years -82.27%
7Years -48.36%
10Years -149.99%
-7.12% ROE
-7.12%
Averages
1Year -7.12%
3Years -20.17%
5Years -14.54%
7Years -10.16%
10Years -11.75%
-5.80% ROA
-5.80%
Averages
1Year -5.80%
3Years -15.76%
5Years -11.25%
7Years -7.81%
10Years -9.80%
-4.15% ROIC
-4.15%
Averages
1Year -4.15%
3Years -12.04%
5Years -6.57%
7Years -4.84%
10Years -4.18%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Tilray Brands, Inc.
image
Net Income -222 M
Depreciation & Amortization 127 M
Capital Expenditures -29.2 M
Stock-Based Compensation 0
Change in Working Capital -8.87 M
Others 103 M
Free Cash Flow -60.2 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Tilray Brands, Inc.
image
Wall Street analysts predict an average 1-year price target for TLRY of $2.59 , with forecasts ranging from a low of $2 to a high of $4.15 .
TLRY Lowest Price Target Wall Street Target
2 USD 66.67%
TLRY Average Price Target Wall Street Target
2.59 USD 116.07%
TLRY Highest Price Target Wall Street Target
4.15 USD 245.83%
4. DIVIDEND ANALYSIS
5. COMPETITION

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany.

image
-47.3 USD
CGC
Overvalued 2267.84%

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States.

image
-12.4 USD
CRON
Overvalued 724.92%

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments.

image
-1.88 USD
SNDL
Overvalued 205.51%

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities.

image
-26.1 USD
ACB
Overvalued 778.26%

Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.

image
0.631 USD
OGI
Overvalued 59.29%
6. Ownership
Insider Ownership Tilray Brands, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
35.4 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
34.8 K USD 2
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Nov 15, 2024
Bought 35.4 K USD
Merton Carl A
Chief Financial Officer
+ 26000
 1.36 USD
1 year ago
Jan 17, 2024
Bought 20.5 K USD
FALTISCHEK DENISE M
Chief Strategy Officer
+ 10000
 2.05 USD
1 year ago
Jan 16, 2024
Bought 14.3 K USD
Gendel Mitchell
Global General Counsel
+ 7200
 1.98 USD
1 year ago
Jan 12, 2024
Bought 10.1 K USD
Gendel Mitchell
Global General Counsel
+ 5400
 1.87 USD
1 year ago
Jan 12, 2024
Bought 101 K USD
SIMON IRWIN D
President and CEO
+ 53700
 1.88 USD
1 year ago
Jan 12, 2024
Bought 37.4 K USD
Merton Carl A
Chief Financial Officer
+ 20000
 1.87 USD
2 years ago
Nov 07, 2022
Sell 1.32 M USD
Kennedy Brendan
Director
- 350000
 3.7793 USD
2 years ago
Oct 05, 2022
Sell 1.02 M USD
Kennedy Brendan
Director
- 350000
 2.9097 USD
2 years ago
Sep 06, 2022
Sell 1.13 M USD
Kennedy Brendan
director:
- 350000
 3.2229 USD
2 years ago
Aug 05, 2022
Sell 1.37 M USD
Kennedy Brendan
director:
- 350000
 3.9117 USD
2 years ago
Jul 05, 2022
Sell 1.08 M USD
Kennedy Brendan
director:
- 350000
 3.0905 USD
3 years ago
Aug 04, 2021
Sell 4.22 M USD
Kennedy Brendan
- 300000
 14.0809 USD
3 years ago
Aug 05, 2021
Sell 4.34 M USD
Kennedy Brendan
- 300000
 14.4619 USD
3 years ago
Jul 15, 2021
Sell 3.24 M USD
Kennedy Brendan
- 223711
 14.4958 USD
3 years ago
Jul 15, 2021
Sell 1.16 M USD
Kennedy Brendan
- 76289
 15.1787 USD
3 years ago
Jul 16, 2021
Sell 4.21 M USD
Kennedy Brendan
- 300000
 14.0381 USD
3 years ago
Jun 17, 2021
Sell 7.19 M USD
Kennedy Brendan
- 400000
 17.9666 USD
3 years ago
Jun 18, 2021
Sell 6.87 M USD
Kennedy Brendan
- 400000
 17.1851 USD
3 years ago
Jun 03, 2021
Sell 468 K USD
Meiers James R.
- 23826
 19.64 USD
3 years ago
May 12, 2021
Sell 1.32 M USD
Merton Carl A
- 89000
 14.82 USD
4 years ago
Dec 16, 2020
Sell 22 K USD
St.Clare Christine
Director
- 2200
 10 USD
4 years ago
Nov 06, 2020
Sell 1.17 M USD
Kennedy Brendan
President and CEO
- 130088
 9.001 USD
4 years ago
Nov 06, 2020
Sell 1.48 M USD
Kennedy Brendan
President and CEO
- 148933
 9.96 USD
4 years ago
Nov 06, 2020
Sell 1.27 M USD
Kennedy Brendan
President and CEO
- 118852
 10.72 USD
4 years ago
Nov 06, 2020
Sell 24.9 K USD
Kennedy Brendan
President and CEO
- 2127
 11.708 USD
4 years ago
Nov 06, 2020
Sell 44.2 K USD
St.Clare Christine
Director
- 4400
 10.053 USD
4 years ago
Nov 06, 2020
Sell 48.1 K USD
Dopp Rebekah
Director
- 4812
 10 USD
4 years ago
Nov 05, 2020
Sell 1.99 M USD
Kennedy Brendan
President and CEO
- 272787
 7.2826 USD
4 years ago
Nov 05, 2020
Sell 987 K USD
Kennedy Brendan
President and CEO
- 127213
 7.7584 USD
4 years ago
Nov 04, 2020
Sell 2.42 M USD
Kennedy Brendan
President and CEO
- 400000
 6.038 USD
4 years ago
Oct 16, 2020
Sell 2.24 M USD
Kennedy Brendan
President and CEO
- 400000
 5.5964 USD
4 years ago
Oct 15, 2020
Sell 2.24 M USD
Kennedy Brendan
President and CEO
- 400000
 5.6079 USD
4 years ago
Oct 14, 2020
Sell 2.33 M USD
Kennedy Brendan
President and CEO
- 400000
 5.8283 USD
4 years ago
Sep 23, 2020
Sell 2.44 M USD
Kennedy Brendan
President and CEO
- 500000
 4.8866 USD
4 years ago
Sep 22, 2020
Sell 2.57 M USD
Kennedy Brendan
President and CEO
- 500000
 5.1341 USD
4 years ago
Sep 21, 2020
Sell 2.5 M USD
Kennedy Brendan
President and CEO
- 500000
 5.0096 USD
4 years ago
Sep 01, 2020
Sell 32.2 K USD
Greenwood Maryscott
Director
- 5000
 6.439 USD
4 years ago
Aug 03, 2020
Sell 2.03 M USD
Auerbach Michael
Director
- 279608
 7.2751 USD
4 years ago
Aug 03, 2020
Sell 549 K USD
Auerbach Michael
Director
- 75526
 7.2746 USD
4 years ago
Aug 03, 2020
Sell 36.4 K USD
Greenwood Maryscott
Director
- 5000
 7.274 USD
4 years ago
Jul 14, 2020
Sell 865 K USD
Kennedy Brendan
President and CEO
- 116666
 7.4169 USD
4 years ago
Jul 15, 2020
Sell 905 K USD
Kennedy Brendan
President and CEO
- 116666
 7.7593 USD
4 years ago
Jul 16, 2020
Sell 897 K USD
Kennedy Brendan
President and CEO
- 116668
 7.6887 USD
4 years ago
Jun 16, 2020
Sell 973 K USD
Kennedy Brendan
President and CEO
- 116666
 8.3418 USD
4 years ago
Jun 17, 2020
Sell 938 K USD
Kennedy Brendan
President and CEO
- 116666
 8.0369 USD
4 years ago
Jun 18, 2020
Sell 959 K USD
Kennedy Brendan
President and CEO
- 116668
 8.2188 USD
4 years ago
May 01, 2020
Sell 702 K USD
Auerbach Michael
Director
- 95131
 7.3817 USD
4 years ago
May 01, 2020
Sell 927 K USD
Auerbach Michael
Director
- 125580
 7.3817 USD
4 years ago
Feb 13, 2020
Sell 1.63 M USD
Kennedy Brendan
President and CEO
- 100000
 16.2759 USD
5 years ago
Jan 13, 2020
Sell 459 K USD
Kennedy Brendan
President and CEO
- 29593
 15.5207 USD
5 years ago
Jan 13, 2020
Sell 1.12 M USD
Kennedy Brendan
President and CEO
- 67113
 16.7381 USD
5 years ago
Jan 13, 2020
Sell 57.1 K USD
Kennedy Brendan
President and CEO
- 3294
 17.3412 USD
5 years ago
Dec 11, 2019
Sell 1.83 M USD
Kennedy Brendan
President and CEO
- 100000
 18.2954 USD
5 years ago
Dec 02, 2019
Sell 144 K USD
Auerbach Michael
Director
- 7537
 19.0508 USD
5 years ago
Dec 02, 2019
Sell 17.8 K USD
Auerbach Michael
Director
- 900
 19.8144 USD
5 years ago
Dec 02, 2019
Sell 607 K USD
Auerbach Michael
Director
- 31875
 19.0508 USD
5 years ago
Jun 20, 2019
Sell 33.4 K USD
Greenwood Maryscott
Director
- 667
 50.0144 USD
5 years ago
Jun 20, 2019
Sell 200 K USD
St.Clare Christine
Director
- 4000
 50.0061 USD
5 years ago
Jun 20, 2019
Sell 197 K USD
Dopp Rebekah
Director
- 3938
 50 USD
5 years ago
Apr 15, 2019
Sell 517 K USD
CASTANEDA MARK
CFO, Secretary, Treasurer
- 10000
 51.72 USD
5 years ago
Apr 05, 2019
Sell 210 K USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 3443
 61.04 USD
5 years ago
Apr 01, 2019
Sell 2.15 M USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 34088
 63.0777 USD
5 years ago
Apr 02, 2019
Sell 179 K USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 2807
 63.7809 USD
5 years ago
Apr 01, 2019
Sell 423 K USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 6600
 64.137 USD
5 years ago
Apr 01, 2019
Sell 198 K USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 3062
 64.8 USD
5 years ago
Apr 01, 2019
Sell 3.33 M USD
Kennedy Brendan
President and CEO
- 52758
 63.034 USD
5 years ago
Apr 02, 2019
Sell 1.21 M USD
Kennedy Brendan
President and CEO
- 18970
 63.7809 USD
5 years ago
Apr 01, 2019
Sell 2.08 M USD
Kennedy Brendan
President and CEO
- 32539
 63.8419 USD
5 years ago
Apr 01, 2019
Sell 119 K USD
Kennedy Brendan
President and CEO
- 1842
 64.7302 USD
5 years ago
Mar 14, 2019
Sell 2.11 M USD
CASTANEDA MARK
CFO, Secretary, Treasurer
- 30000
 70.4272 USD
5 years ago
Mar 01, 2019
Sell 4.28 M USD
Kennedy Brendan
President and CEO
- 53897
 79.49 USD
5 years ago
Mar 01, 2019
Sell 1.16 M USD
Kennedy Brendan
President and CEO
- 14437
 80.4 USD
5 years ago
Mar 01, 2019
Sell 609 K USD
Kennedy Brendan
President and CEO
- 7454
 81.6688 USD
5 years ago
Mar 01, 2019
Sell 932 K USD
Kennedy Brendan
President and CEO
- 11351
 82.1351 USD
5 years ago
Feb 25, 2019
Sell 2.41 M USD
CASTANEDA MARK
CFO, Secretary, Treasurer
- 30903
 77.8899 USD
5 years ago
Feb 25, 2019
Sell 645 K USD
CASTANEDA MARK
CFO, Secretary, Treasurer
- 8197
 78.6847 USD
5 years ago
Feb 25, 2019
Sell 71.4 K USD
CASTANEDA MARK
CFO, Secretary, Treasurer
- 900
 79.38 USD
5 years ago
Jan 28, 2019
Sell 2.14 M USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 29422
 72.57 USD
5 years ago
Jan 24, 2019
Sell 11.1 M USD
Kennedy Brendan
President and CEO
- 149916
 74.2092 USD
5 years ago
Jan 24, 2019
Sell 1.53 M USD
Pastorius Edward Wood JR
Chief Revenue Officer
- 20578
 74.2092 USD
6 years ago
Jul 23, 2018
Bought 250 K USD
CASTANEDA MARK
CFO, Secretary, Treasurer
+ 14705
 17 USD
6 years ago
Jul 23, 2018
Bought 250 K USD
Pastorius Edward Wood JR
Chief Revenue Officer
+ 14705
 17 USD
6 years ago
Jul 23, 2018
Bought 250 K USD
Kennedy Brendan
President and CEO
+ 14706
 17 USD
7. News
Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Tilray Medical , a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg highlights the trust placed in Tilray Medical to deliver high-quality medical cannabis on a consistent basis across the global medical cannabis industry. globenewswire.com - 1 week ago
Will the Tilray Brands stock price rise or fall after earnings? The Tilray Brands stock price has crawled back in the past few days, rising from the December low of $1.15 to $1.45. This mini-rebound will be put to test when the cannabis company publishes its financial results later this week. invezz.com - 1 week ago
Tilray Brands, Inc. (TLRY) Stock Sinks As Market Gains: Here's Why In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.45, denoting a -0.68% change from the preceding trading day. zacks.com - 2 weeks ago
Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ended November 30, 2024, before the financial market opens on January 10, 2025. The Company originally scheduled the release of its second quarter financial results before market open on January 9, 2025. globenewswire.com - 2 weeks ago
Tilray CEO on 'how to make beer and beverages cool again' Irwin Simon, Tilray CEO, discusses outlooks on the beverage and cannabis industries. youtube.com - 2 weeks ago
We think Trump may support cannabis legalization, says Tilray CEO Irwin Simon Irwin Simon, Tilray CEO, joins CNBC's 'Money Movers' to discuss outlooks on the cannabis industry, the year ahead for Tilray, and more. youtube.com - 2 weeks ago
Here's Why Tilray Brands' CEO Is Optimistic Marijuana Legalization Will Happen Under the Trump Administration For many pot stocks, their share prices can often rise or fall rapidly depending on the outlook for marijuana legalization in the U.S. That's because there is significant growth potential in the industry, but a lot depends on whether there is progress on legalization both in more states permitting access and overall federal legalization. fool.com - 2 weeks ago
New Year, New Chill: Explore the Latest Cannabis Beverages from Solei, Mollo, and XMG TORONTO, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer goods company, offers a wide range of innovative and refreshing cannabis beverages for every taste, perfect for any occasion. Consumers are invited to explore the Solei, Mollo, and XMG cannabis brands in Canada for a variety of cannabinoid offerings and flavours, catering to different lifestyles. globenewswire.com - 2 weeks ago
This 1 Metric Shows Why You Should Be Cautious With Tilray Brands Stock While it's often narratives rather than numbers that cause stocks to swing in value, sometimes the most parsimonious way to summarize a company's strengths and weaknesses is to focus on a key quantitative metric or two. Numbers never tell the whole story, but they can often give investors some pretty solid hints about what's coming next. fool.com - 3 weeks ago
Tilray stock faces challenges despite potential Trump 2.0 cannabis legalization Tilray Inc (NASDAQ: TLRY) chief executive Irwin Simon expects the recreational use of cannabis to be legalised on a federal level under Donald Trump as the President of the United States. In other words, he expects legalisation to occur over the next four years. invezz.com - 3 weeks ago
Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy? It's not a secret: The cannabis industry has been a major disappointment since Canada legalized recreational use in 2018. Some companies in the industry diversified away from their cannabis operations as a result. fool.com - 4 weeks ago
Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should Know In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $1.16, marking no change from the previous day. zacks.com - 1 month ago
8. Profile Summary

Tilray Brands, Inc. TLRY

image
COUNTRY CA
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 1.13 B
Dividend Yield 0.00%
Description Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Contact 265 Talbot Street West, Leamington, ON, N8H 5L4 https://www.tilray.com
IPO Date July 19, 2018
Employees 2650
Officers Ms. Berrin Noorata Chief Corporate Affairs Officer Mr. Mitchell S. Gendel J.D. Global General Counsel & Corporate Secretary Mr. Roger Savell Chief Administrative Officer & Chief Financial Officer of International Ms. Nyree Pinto Chief Human Resources Officer Mr. Ty H. Gilmore President of U.S. Beer Mr. Blair MacNeil CMA, CPA President of Tilray Canada Mr. Irwin David Simon President, Chief Executive Officer & Chairman Mr. Carl A. Merton CA, CBV, CPA Chief Financial Officer & Principal Accounting Officer Ms. Denise Menikheim Faltischek Chief Strategy Officer & Head of International Mr. Lloyd Brathwaite Chief Information Officer